Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Pharmacogenomics J ; 14(1): 63-9, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23529008

RESUMO

Synapsins are neuronal phosphoproteins crucial to regulating the processes required for normal neurotransmitter release. Synapsin II, in particular, has been implied as a candidate gene for schizophrenia. This study investigated synapsin II mRNA expression, using real-time reverse transcriptase-PCR, in coded dorsolateral prefrontal cortical samples provided by the Stanley Foundation Neuropathology Consortium. Synapsin IIa was decreased in patients with schizophrenia when compared with both healthy subjects and patients with bipolar disorder, whereas synapsin IIb was only significantly reduced in patients with schizophrenia when compared with healthy subjects but not in patients with bipolar disorder. Furthermore, lifetime antipsychotic drug use was positively associated with synapsin IIa expression in patients with schizophrenia. Results suggest that impairment of synaptic transmission by synapsin II reduction may contribute to dysregulated convergent molecular mechanisms, which result in aberrant neural circuits that characterize schizophrenia, while implicating involvement of synapsin II in therapeutic mechanisms of currently prescribed antipsychotic drugs.


Assuntos
Antipsicóticos/uso terapêutico , Transtorno Bipolar/tratamento farmacológico , Expressão Gênica/efeitos dos fármacos , Córtex Pré-Frontal/efeitos dos fármacos , Esquizofrenia/tratamento farmacológico , Sinapsinas/genética , Antipsicóticos/administração & dosagem , Transtorno Bipolar/genética , Transtorno Bipolar/patologia , Transtorno Bipolar/fisiopatologia , Estudos de Casos e Controles , Relação Dose-Resposta a Droga , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Córtex Pré-Frontal/metabolismo , Reação em Cadeia da Polimerase em Tempo Real , Esquizofrenia/genética , Esquizofrenia/patologia , Esquizofrenia/fisiopatologia , Transmissão Sináptica/efeitos dos fármacos , Transmissão Sináptica/genética , Fatores de Tempo
2.
Med Trop (Mars) ; 70(3): 229-38, 2010 Jun.
Artigo em Francês | MEDLINE | ID: mdl-20734589

RESUMO

Mauritius is an island nation off the coast of Africa in the southwestern Indian Ocean. Improved socio-sanitation conditions over the past years have dramatically decreased the incidence of tropical diseases to levels comparable with those observed in developed countries. Some tropical illnesses including malaria, schistosomiasis, cysticercosis and lymphatic filariasis have been eradicated. Others such as amibiasis, typhoid fever and leprosy have become rare. However, because of the island's geographical proximity to countries with uncontrolled and suboptimal socio-sanitation conditions and its humid subtropical climate, there is a continued risk for certain vector transmitted tropical diseases such as Chikungunya and dengue. In addition, the incidence of HIV infection and AIDS has been rising rapidly since 2004 and tuberculosis remains a public health problem. Better living conditions have also been accompanied by an increase in cardiovascular and metabolic diseases that, along with cancer, are now the main causes of morbidity and mortality.


Assuntos
Doenças Transmissíveis/epidemiologia , Doenças Parasitárias/epidemiologia , Saúde Pública , Infecções por Alphavirus/epidemiologia , Doenças Cardiovasculares/epidemiologia , Vírus Chikungunya/isolamento & purificação , Doença Crônica/epidemiologia , Dengue/epidemiologia , Países em Desenvolvimento , Infecções por HIV/epidemiologia , Humanos , Incidência , Hanseníase/epidemiologia , Maurício/epidemiologia , Doenças Metabólicas/epidemiologia , Neoplasias/epidemiologia , Doenças Parasitárias/prevenção & controle , Saúde Pública/estatística & dados numéricos , Tuberculose/epidemiologia , Febre Tifoide/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA